Your browser doesn't support javascript.
loading
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Stein, Eytan M; DiNardo, Courtney D; Fathi, Amir T; Mims, Alice S; Pratz, Keith W; Savona, Michael R; Stein, Anthony S; Stone, Richard M; Winer, Eric S; Seet, Christopher S; Döhner, Hartmut; Pollyea, Daniel A; McCloskey, James K; Odenike, Olatoyosi; Löwenberg, Bob; Ossenkoppele, Gert J; Patel, Prapti A; Roshal, Mikhail; Frattini, Mark G; Lersch, Frederik; Franovic, Aleksandra; Nabhan, Salah; Fan, Bin; Choe, Sung; Wang, Hongfang; Wu, Bin; Hua, Lei; Almon, Caroline; Cooper, Michael; Kantarjian, Hagop M; Tallman, Martin S.
Afiliação
  • Stein EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • DiNardo CD; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fathi AT; Dana-Faber/Harvard Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Mims AS; Ohio State University Wexner Medical Center, Columbus, OH.
  • Pratz KW; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Savona MR; Vanderbilt-Ingram Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Stein AS; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA.
  • Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Seet CS; Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, CA.
  • Döhner H; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Pollyea DA; Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
  • McCloskey JK; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Odenike O; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL.
  • Löwenberg B; Department of Hematology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Ossenkoppele GJ; Department of Hematology, VUmc Cancer Center, Amsterdam, The Netherlands.
  • Patel PA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
  • Roshal M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Frattini MG; Bristol-Myers Squibb, Summit, NJ.
  • Lersch F; Celgene International, Boudry, Switzerland.
  • Franovic A; Bristol-Myers Squibb, San Francisco, CA; and.
  • Nabhan S; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Fan B; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Choe S; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Wang H; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Wu B; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Hua L; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Almon C; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Cooper M; Agios Pharmaceuticals, Inc., Cambridge, MA.
  • Kantarjian HM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tallman MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Blood ; 137(13): 1792-1803, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33024987

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Triazinas / Leucemia Mieloide Aguda / Glicina / Aminopiridinas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Triazinas / Leucemia Mieloide Aguda / Glicina / Aminopiridinas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article